Technology | November 03, 2009

Texas Cardiac Arrhythmia Institute First in U.S. to Use CARTO 3 Navigation System

November 3, 3009 — On Monday, Andrea Natale, M.D., FACC, FHRS, an electrophysiologist and executive medical director of the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, became the first physician in the United States to perform an ablation procedure to treat a patient with a cardiac arrhythmia using the newly FDA-cleared CARTO 3 Navigation System. "Imaging with the new CARTO 3 System puts us at the forefront of being able to visualize and treat nearly every type of arrhythmia," Dr. Natale said. "It also reinforces our commitment to helping the growing pool of arrhythmia patients get fast, effective treatment." The CARTO 3 Navigation System is a three-dimensional imaging system that allows doctors to quickly and accurately visualize cardiac anatomy. It is especially useful in the treatment of atrial fibrillation, or AFIB. AFIB is the most common type of irregular heart rhythm in the United States, affecting an estimated 5.6 million people, and is increasing due to the rise in the aging population. Texas Cardiac Arrhythmia Institute at St. David's Medical Center offers a full range of electrophysiology procedures, including catheter ablation — for which physicians utilize the only FDA-approved catheter for treating AFIB, the NAVISTAR THERMOCOOL Irrigated Ablation Catheter. THERMOCOOL Navigation Catheters are approved (for drug refractory recurrent symptomatic paroxysmal atrial fibrillation) when used with CARTO 3 Systems. The CARTO 3 System gives doctors the ability to pinpoint the location of these catheters during ablation procedures with speed, precision and clarity. For more information: visit www.StDavids.com/sdmc.aspx


Related Content

News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
News | EP Lab

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
News | EP Lab

August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 17, 2023
Home
News | EP Lab

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
Subscribe Now